title: Histamine and prostaglandin interaction in the central regulation of ACTH secretion.
abstract: Since prostaglandins (PGs) and histamine (HA) seem to be involved in the activation of the hypothalamic-pituitary-adrenal axis following immunochallenges with lipopolysaccharide (LPS) endotoxin and cytokines, we investigated whether the histaminergic and eicosanoid systems in the male rat brain interact in their regulation of ACTH secretion. The PG synthesis inhibitor indomethacin (10 mg/kg i.p.) attenuated the ACTH response to LPS (10 micrograms/kg i.p.) and HA (30 micrograms i.c.v.). Infusion of PGE1, PGE2 or PGF2 alpha (1 and/or 5 micrograms infused intracerebroventricularly) stimulated ACTH secretion. The ACTH response to PGE1 was inhibited by the HA synthesis inhibitor alpha-fluoromethyl-histidine and the H1 receptor antagonist mepyramine (MEP) but not the H2 receptor antagonist cimetidine (CIM). Neither MEP nor CIM affected the ACTH response to PGE2. MEP and CIM attenuated the ACTH response induced by PGF2 alpha. The findings indicate that HA and some PGs in the brain interact in their stimulatory regulation of ACTH secretion. Such an interaction may also be involved in their mediation of the ACTH response to immunochallenges.
authors.affiliation: Department of Medical Physiology, Rigshospitalet, University of Copenhagen, Denmark.
authors.forename: M
authors.initials: M
authors.lastname: Anthonisen
authors.forename: U
authors.initials: U
authors.lastname: Knigge
authors.forename: A
authors.initials: A
authors.lastname: Kjaer
authors.forename: J
authors.initials: J
authors.lastname: Warberg
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000527:Alprostadil / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology; D000818:Animals; D019138:Antibodies, Blocking / Q000494:pharmacology; D002490:Central Nervous System / Q000502:physiology*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015237:Dinoprost / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology; D015232:Dinoprostone / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology; D006632:Histamine / Q000502:physiology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007276:Injections, Intraventricular; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D011453:Prostaglandins / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D019138:Antibodies, Blocking; D016861:Cyclooxygenase Inhibitors; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D008070:Lipopolysaccharides; D011453:Prostaglandins; D006632:Histamine; D000324:Adrenocorticotropic Hormone; D015237:Dinoprost; D000527:Alprostadil; D015232:Dinoprostone; D007213:Indomethacin